ABSTRACT
This project outlined use of the diffusion of innovations model to disseminate bone marrow transplantation technology for the cure of sickle cell anemia and other hemoglobinopathies. Besides, we Identified technologically developed nations that have the relevant medical workforce and infrastructures for BMT. Also discussed, is the necessity of equipping transplant facilities with the construction of the CLEAN ROOM with the state- of- the science resources to protect SCD patients from nosocomial infections. To save human lives and avoid unnecessary casualties, the medical team must protect their patients from hospital acquired infections (HAI), nosocomial and iatrogenic diseases during administration of transplant innovative device. Medical institutions must maintain continuity in sustainable, scientific workforce development. Finally, we explored the ethical, legal, social, and financial implications of adopting Bone Marrow Transplantation medical innovations to cure sickle cell anemia.
ABSTRACT
This project investigated genomic epidemiology of congestive heart disease, the clinical and non-invasive techniques for diagnosis and the modifiable and non-modifiable risk factors associated with the disease were explored. Trends in the morbidity and mortality of CHD revealed an increase in the disease frequency with minor drop in its’ trajectory into the twenty-first century. While the modifiable risk factors were discussed with suitable interventions, the non-modifiable risk factors demand prompt medical diagnosis and treatment if any. The genes incriminated were listed. The relevance of pharmacogenomics cannot be overstated in the age of genomic medical science. But by far most important is the consumption of food items rich in phyto-nutrients to maximize public health and minimize the impact of dangerous lipids in our diet.